NCT00118170
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +83 more
- Locations
-
- Cancer and Leukemia Group B (CALGB) Research Base Chicago, Illinois, United States
Clinical trial condition
Recurrent Grade 3 Follicular Lymphoma
Explore clinical trials studying Recurrent Grade 3 Follicular Lymphoma. Study availability and eligibility vary by location and protocol.
99 public trials
0 recruiting studies
Recurrent Grade 3 Follicular Lymphoma trial results
NCT00022581
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +20 more
- Locations
-
- Cancer and Leukemia Group B (CALGB) Research Base Chicago, Illinois, United States
NCT00799461
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +154 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Megakaryoblastic Leukemia (M7), +136 more
- Locations
-
- Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
Active, Not Recruiting
Rituxan/Bendamustine/PCI-32765 in Relapsed DLBCL, MCL, or Indolent Non-Hodgkin's Lymphoma
NCT01479842
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, +29 more
- Locations
-
- Ohio State University Medical Center Columbus, Ohio, United States
Active, Not Recruiting
Genetically Modified T-cell Infusion Following Peripheral Blood Stem Cell Transplant in Treating Patients With Recurrent or High-Risk Non-Hodgkin Lymphoma
NCT01815749
- Conditions
- Adult Grade III Lymphomatoid Granulomatosis, Blood Protein Disorders, Burkitt Lymphoma, +64 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Active, Not Recruiting
Genetically Engineered Lymphocyte Therapy After Peripheral Blood Stem Cell Transplant in Treating Patients With High-Risk, Intermediate-Grade, B-cell Non-Hodgkin Lymphoma
NCT01318317
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +13 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Active, Not Recruiting
Ibrutinib in Treating Patients With Relapsed or Refractory Follicular Lymphoma
NCT01849263
- Conditions
- Grade 3a Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic in Florida Jacksonville, Florida, United States
- Mayo Clinic in Rochester Rochester, Minnesota, United States
- Metro Minnesota Community Oncology Research Consortium Saint Louis Park, Minnesota, United States
Active, Not Recruiting
Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant
NCT01199562
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, +245 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States